Planning Strategies’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Planning Strategies's CRL Position: Q3 2026 in Review
Planning Strategies held its Charles River Laboratories (CRL) position steady in Q3 2026 at 8 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #587.
Planning Strategies first reported a position in CRL in Q2 2026 and has held it in 2 quarters since. 642 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Planning Strategies held 8 shares of Charles River Laboratories worth $2.36K as of Q3 2026.
- Planning Strategies left its Charles River Laboratories share count unchanged in Q3 2026.
- Charles River Laboratories made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #587 holding.
- Planning Strategies first reported a position in Charles River Laboratories in Q2 2026 and has held it in 2 quarters since.
- 642 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.